The ‘Dry Eye Disease Market’ research report delivers a comprehensive analysis on the newest market drivers. The report also offers extracts regarding statistics, market valuation and revenue estimates, which further strengthens its status in the competitive spectrum and growth trends embraced by leading manufacturers in the business.
Dry Eye Disease Market is valued around USD 2796.8 Million in 2018 and expected to reach USD 3778.1 Million by 2025 with the CAGR of 4.7% over the forecast period.
Dry eye disease is a disease caused due to the lack of tears or lubrication in eyes which led to the burning sensation and redness in eyes. These tears provide lubrication and each blink spread tears evenly and provide nourishment to the eyes. When the production and drainage of tears are not balanced then it leads to the dry eye disease. This condition is most common in older population and there are various environmental conditions which are responsible for such condition in young adults as well. The few symptoms experienced by the people suffering from dry eye disease are irritation, burning sensation, blurred vision and advanced stage may also lead to the vision impairment. So, during the study of global dry eye disease market, we have considered product type and distribution channel to analyze the market.
The regions covered in this dry eye disease market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, market of Dry Eye Disease is sub divided into U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.
Key Players for Global Dry Eye Disease Market Reports–
Global dry eye disease market report covers prominent players like Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Allergan plc, Shire plc, TRB Chemedica International SA, Mitotech S.A., Sun Pharmaceutical Industries Ltd., Senju Pharmaceutical Co., Ltd., Sentiss Pharma Pvt. Ltd., Valeant Pharmaceuticals International, Inc., Otsuka Pharmaceutical Co., Ltd., Novartis AG, FCI S.A.S. and others.
North America is Expected to Dominate the Dry Eye Disease Market
North America dominates the market with highest market share over the forecast period due to the increased adoption of prescription drugs for dry eye disease and increase in the approval of various new drugs developed by the majr market players. Europe is expected to the second largest growing region over the forecast period due to the technological advancements and research and development activities which led to the development of new drugs and devices. Asia Pacific is expected to be the third largest and fastest growing region over the forecast period. Due to the increased awareness among people, large patient pool, increase in healthcare facilities and increase in per capita income are expected to promote the growth of dry eye disease market over the forecast period. Latin America, Middle East and Africa are expected to develop considerably over the forecast period.
Key Benefits for Global Dry Eye Disease Market Reports –
Global Dry Eye Disease Market Segmentation –
By Product Type analysis:
Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs, Secretagogue
By Distribution Channel Analysis
Hospital Pharmacies, Independent Pharmacies and Drug Stores, Online Pharmacies
Get Sample Copy of This Premium Report @https://brandessenceresearch.com/requestSample/PostId/257
Interested in this report?